The microbiota as seen by the experts
Monday may-09-2022
15h-18h-Amphitéatre Deguit
Pôle Juridique et Judiciaire, place Pey Berland, 33000 Bordeaux.
14h-Meeting with the SBMyoung group.
15h-Introduction: Mr le Directeur Général-CHU Mr Yann Bubien et Pr Philippe Lehours
15h05-Plenary talks: Microbiota view from international experts
(chair: Pr F Mégraud and Pr L Delhaes)
15h05-15h25-Pr Maria Gloria Dominguez Bello, Department of Biochemistry and Microbiology, Robert Wood Johnson Medical School, Rutgers university, New Jersey: “The human microbiome in the anthropocene.”
15h25-15h35: questions
15h35-15h55-Pr Martin J Blaser, Departments of Medicine and Pathology & Laboratory Medicine, RBHS, Robert Wood Johnson Medical School, Rutgers university, New Jersey: “The double-edged sword of antibiotics.”
16h55-16h05: questions
-Pr Claire Andrejak, CHU de Amiens, service de Pneumologie:« Pulmonary Microbiote, what do we know (or don’t know) in 2022 ?”
16h20-16h25: questions
16h25-16h40: Coffee Break
16h40-Symposium: "The microbiota in Bordeaux: crossed views of senior researchers"(Chairwoman: Pr C Roubaud Baudron)
16h40-16h55-Pr Maya Saleh, Immunoconcept, CNRS UMR 5164 – University of Bordeaux: « Exploring the role of the microbiome in patients response to cancer immunotherapies».
16h55-17h05: questions
17h05-17h20-Pr David Laharie, CHU de Bordeaux, service de gastroentérologie: « Deciphering host-microbiota crosstalk in acute severe ulcerative colitis »
17h20-17h35: questions
17h35-Symposium: "The microbiota in Bordeaux: crossed views of young scientific researchers" (Chairwomen: Pr L Delhaes, Dr E Bessède)
Symposium: "The microbiota in Bordeaux: crossed views of young scientific researchers"
17h25-17h35-Marine Jauvain, INSERM U1312, BRIC, Team 4, University of Bordeaux and CHU de Bordeaux, Laboratoire de Bactériologie, CNR des Campylobacters et des Hélicobacters: Metformin modifies the gut microbiota of mice infected with Helicobacter pylori.
17h35-17h40-Julie Giraud, Immunoconcept, CNRS UMR 5164 – University of Bordeaux: A role of intra-tumoral bacteria in HCC?
17h40-17h50-Eléna Charpentier - Mycology department, Bordeaux CHU & Inserm U1045: Mycobiota: An emerging component that FANCy helps to decipher by predicting the functional potential of a fungal community.
17h50-18h- Raphael Enaud - Paediatric CRCM, Bordeaux CHU & Inserm U1045: Impacts of CFTR modulators on the airway and gut mycobiota-microbiota in patients with cystic fibrosis.
Organizing committee: Pr L Delhaes, Pr C Roubaud Baudron, Dr E Bessède, Pr F Mégraud, Pr P Lehours.
Inscription gratuite et fortement recommandée, places limitées
Inscription
Professeur de médecine et de microbiologie et directeur du Center for Advanced Biotechnology and Medicine à l'Université Rutgers (New Jersey), Martin J. Blaser recevra le titre de Docteur Honoris Causa de l’Université de Bordeaux en 2022. Philippe Lehours, (BRIC) Directeur du CNR des Campylobacters et Hélicobacters du CHU de Bordeaux, a passé 5 mois aux côtés de Martin J. Blaser. Il nous parle de cet imminent chercheur.